{
  "meta": {
    "version": "1.0.0",
    "description": "Curated database of HLA allele associations with Type 2 Diabetes, LADA, and related metabolic phenotypes",
    "sources": [
      "Howson et al. 2011 - HLA class II gene associations in T2D (Diabetologia)",
      "Jacobsen et al. 2018 - HLA and T2D risk in Scandinavian cohorts",
      "Yasuda et al. 2016 - HLA-DRB1 and T2D in Japanese populations (J Hum Genet)",
      "Tuomi et al. 2014 - Latent autoimmune diabetes in adults (Diabetes Care)",
      "Buzzetti et al. 2017 - LADA management: NIRAD study (Diabetes Care)",
      "Mahajan et al. 2018 - Multi-ancestry GWAS of T2D (Nature Genetics)",
      "GWAS Catalog, IPD-IMGT/HLA Database, dbMHC"
    ],
    "build": "GRCh38/hg38",
    "mhc_region": {
      "chromosome": "6",
      "start": 28510120,
      "end": 33480577,
      "length_mb": 4.97,
      "description": "Major Histocompatibility Complex (MHC) on chromosome 6p21.3. Contains ~260 genes, the most gene-dense and polymorphic region in the human genome."
    },
    "last_updated": "2025-12-01"
  },
  "hla_genes": {
    "HLA-A": {
      "full_name": "Major Histocompatibility Complex, Class I, A",
      "class": "I",
      "chromosome_position": {"start": 29942470, "end": 29945884},
      "function": "Presents intracellular peptides to CD8+ T cells. Involved in NK cell regulation via KIR interactions.",
      "role_in_t2d": "Indirect role through NK cell-mediated adipose tissue inflammation and beta-cell stress.",
      "structure": {"chains": ["alpha"], "domains": ["alpha1", "alpha2", "alpha3"], "binds": "8-10mer peptides"},
      "color": "#e74c3c"
    },
    "HLA-B": {
      "full_name": "Major Histocompatibility Complex, Class I, B",
      "class": "I",
      "chromosome_position": {"start": 31353872, "end": 31357179},
      "function": "Presents intracellular peptides to CD8+ cytotoxic T cells. Most polymorphic class I gene.",
      "role_in_t2d": "Modulates inflammatory response in metabolic syndrome. Some alleles affect beta-cell autoimmunity threshold.",
      "structure": {"chains": ["alpha"], "domains": ["alpha1", "alpha2", "alpha3"], "binds": "8-10mer peptides"},
      "color": "#e67e22"
    },
    "HLA-C": {
      "full_name": "Major Histocompatibility Complex, Class I, C",
      "class": "I",
      "chromosome_position": {"start": 31268749, "end": 31272092},
      "function": "Ligand for KIR receptors on NK cells. Regulates innate immune activation threshold.",
      "role_in_t2d": "KIR/HLA-C interactions modulate adipose tissue macrophage polarization and insulin resistance.",
      "structure": {"chains": ["alpha"], "domains": ["alpha1", "alpha2", "alpha3"], "binds": "8-10mer peptides"},
      "color": "#f39c12"
    },
    "HLA-DRB1": {
      "full_name": "Major Histocompatibility Complex, Class II, DR Beta 1",
      "class": "II",
      "chromosome_position": {"start": 32578769, "end": 32589848},
      "function": "Presents extracellular peptides to CD4+ helper T cells. Key determinant of adaptive immune response specificity.",
      "role_in_t2d": "Central role in T2D-associated inflammation. Specific alleles modulate Th1/Th2/Th17 balance affecting insulin resistance and beta-cell autoimmunity in LADA.",
      "structure": {"chains": ["alpha", "beta"], "domains": ["alpha1", "beta1"], "binds": "13-25mer peptides"},
      "color": "#3498db"
    },
    "HLA-DQA1": {
      "full_name": "Major Histocompatibility Complex, Class II, DQ Alpha 1",
      "class": "II",
      "chromosome_position": {"start": 32637406, "end": 32643652},
      "function": "Alpha chain of HLA-DQ heterodimer. Forms peptide-binding groove with DQB1.",
      "role_in_t2d": "DQA1/DQB1 haplotypes are the strongest HLA determinants of autoimmune diabetes risk, relevant for LADA classification.",
      "structure": {"chains": ["alpha"], "domains": ["alpha1"], "binds": "with DQB1"},
      "color": "#2980b9"
    },
    "HLA-DQB1": {
      "full_name": "Major Histocompatibility Complex, Class II, DQ Beta 1",
      "class": "II",
      "chromosome_position": {"start": 32659467, "end": 32666657},
      "function": "Beta chain of HLA-DQ heterodimer. Contains the primary polymorphic residues in the peptide-binding groove.",
      "role_in_t2d": "Position 57 (Asp vs non-Asp) is the single most important residue for diabetes risk. DQB1*06:02 is strongly protective, DQB1*03:02 confers risk.",
      "structure": {"chains": ["beta"], "domains": ["beta1"], "binds": "with DQA1"},
      "color": "#1abc9c"
    },
    "HLA-DPB1": {
      "full_name": "Major Histocompatibility Complex, Class II, DP Beta 1",
      "class": "II",
      "chromosome_position": {"start": 33075926, "end": 33089696},
      "function": "Beta chain of HLA-DP. Less studied than DR/DQ but emerging role in metabolic inflammation.",
      "role_in_t2d": "Weaker associations reported. May modulate macrophage antigen presentation in adipose tissue.",
      "structure": {"chains": ["beta"], "domains": ["beta1"], "binds": "with DPA1"},
      "color": "#8e44ad"
    }
  },
  "allele_associations": [
    {
      "allele": "HLA-DRB1*15:01",
      "gene": "HLA-DRB1",
      "class": "II",
      "association": "protective",
      "phenotype": "T2D",
      "odds_ratio": 0.72,
      "ci_lower": 0.63,
      "ci_upper": 0.82,
      "p_value": 3.2e-6,
      "frequency_european": 0.14,
      "frequency_asian": 0.08,
      "frequency_african": 0.06,
      "frequency_latin_american": 0.09,
      "description": "Consistently protective against T2D across European populations. Associated with lower HbA1c and improved insulin sensitivity. Part of the DR15-DQ6 haplotype.",
      "mechanism": "Promotes Treg differentiation and anti-inflammatory cytokine profile in adipose tissue. Enhances tolerance to islet autoantigens.",
      "haplotype": "DRB1*15:01-DQA1*01:02-DQB1*06:02",
      "evidence_level": "A",
      "key_references": ["PMID:21874358", "PMID:29632382"]
    },
    {
      "allele": "HLA-DRB1*03:01",
      "gene": "HLA-DRB1",
      "class": "II",
      "association": "risk",
      "phenotype": "T2D/LADA",
      "odds_ratio": 1.85,
      "ci_lower": 1.55,
      "ci_upper": 2.21,
      "p_value": 1.8e-10,
      "frequency_european": 0.12,
      "frequency_asian": 0.03,
      "frequency_african": 0.10,
      "frequency_latin_american": 0.07,
      "description": "Strong risk allele for LADA (Latent Autoimmune Diabetes in Adults) and GAD-antibody positive T2D. The hallmark LADA HLA allele.",
      "mechanism": "Presents islet autoantigens (GAD65, IA-2) to CD4+ T cells, triggering autoimmune beta-cell destruction. Activates Th1 pathways.",
      "haplotype": "DRB1*03:01-DQA1*05:01-DQB1*02:01",
      "evidence_level": "A",
      "key_references": ["PMID:24595630", "PMID:28540917"]
    },
    {
      "allele": "HLA-DRB1*04:01",
      "gene": "HLA-DRB1",
      "class": "II",
      "association": "risk",
      "phenotype": "T2D/LADA",
      "odds_ratio": 1.62,
      "ci_lower": 1.35,
      "ci_upper": 1.94,
      "p_value": 4.5e-7,
      "frequency_european": 0.08,
      "frequency_asian": 0.05,
      "frequency_african": 0.03,
      "frequency_latin_american": 0.10,
      "description": "Risk for both T1D and LADA. In T2D context, especially relevant for adult-onset autoimmune diabetes. Synergizes with DRB1*03:01.",
      "mechanism": "High-affinity presentation of proinsulin and GAD65 epitopes. DRB1*04:01/03:01 heterozygotes have highest LADA risk.",
      "haplotype": "DRB1*04:01-DQA1*03:01-DQB1*03:02",
      "evidence_level": "A",
      "key_references": ["PMID:21874358", "PMID:28540917"]
    },
    {
      "allele": "HLA-DRB1*09:01",
      "gene": "HLA-DRB1",
      "class": "II",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.45,
      "ci_lower": 1.22,
      "ci_upper": 1.72,
      "p_value": 8.3e-5,
      "frequency_european": 0.02,
      "frequency_asian": 0.15,
      "frequency_african": 0.01,
      "frequency_latin_american": 0.04,
      "description": "Risk allele specific to East Asian populations (Japanese, Chinese, Korean). One of the strongest T2D-HLA associations in non-European ancestry.",
      "mechanism": "Promotes inflammatory macrophage activation in visceral adipose tissue. May enhance presentation of bacterial peptides from gut dysbiosis.",
      "haplotype": "DRB1*09:01-DQA1*03:02-DQB1*03:03",
      "evidence_level": "A",
      "key_references": ["PMID:26818947"]
    },
    {
      "allele": "HLA-DRB1*07:01",
      "gene": "HLA-DRB1",
      "class": "II",
      "association": "protective",
      "phenotype": "T2D/LADA",
      "odds_ratio": 0.68,
      "ci_lower": 0.55,
      "ci_upper": 0.84,
      "p_value": 2.1e-4,
      "frequency_european": 0.13,
      "frequency_asian": 0.05,
      "frequency_african": 0.08,
      "frequency_latin_american": 0.07,
      "description": "Protective against LADA and autoimmune T2D in European populations. Counteracts autoimmune beta-cell destruction.",
      "mechanism": "Poor presenter of key islet autoantigens. Promotes Th2 skewing and IL-10 production.",
      "haplotype": "DRB1*07:01-DQA1*02:01-DQB1*02:02",
      "evidence_level": "B",
      "key_references": ["PMID:24595630"]
    },
    {
      "allele": "HLA-DRB1*13:01",
      "gene": "HLA-DRB1",
      "class": "II",
      "association": "protective",
      "phenotype": "T2D",
      "odds_ratio": 0.75,
      "ci_lower": 0.61,
      "ci_upper": 0.92,
      "p_value": 5.6e-3,
      "frequency_european": 0.06,
      "frequency_asian": 0.04,
      "frequency_african": 0.10,
      "frequency_latin_american": 0.08,
      "description": "Protective in multiple populations. Associated with better metabolic profile and lower inflammatory markers.",
      "mechanism": "Promotes regulatory T cell activity. Associated with lower TNF-alpha and IL-6 in metabolic syndrome.",
      "haplotype": "DRB1*13:01-DQA1*01:03-DQB1*06:03",
      "evidence_level": "B",
      "key_references": ["PMID:29632382"]
    },
    {
      "allele": "HLA-DQB1*06:02",
      "gene": "HLA-DQB1",
      "class": "II",
      "association": "protective",
      "phenotype": "T2D/LADA/T1D",
      "odds_ratio": 0.45,
      "ci_lower": 0.35,
      "ci_upper": 0.58,
      "p_value": 2.8e-12,
      "frequency_european": 0.14,
      "frequency_asian": 0.06,
      "frequency_african": 0.08,
      "frequency_latin_american": 0.07,
      "description": "The most protective HLA allele against autoimmune diabetes. Asp57 in the peptide-binding groove is the key protective residue. Strongly protective against both T1D and LADA component of T2D.",
      "mechanism": "Asp57 forms a salt bridge with Arg76 of HLA-DQA1, stabilizing the P9 pocket. This prevents high-affinity binding of diabetogenic peptides from insulin and GAD65.",
      "haplotype": "DRB1*15:01-DQA1*01:02-DQB1*06:02",
      "evidence_level": "A",
      "key_references": ["PMID:21874358", "PMID:24595630"]
    },
    {
      "allele": "HLA-DQB1*03:02",
      "gene": "HLA-DQB1",
      "class": "II",
      "association": "risk",
      "phenotype": "T2D/LADA",
      "odds_ratio": 1.78,
      "ci_lower": 1.48,
      "ci_upper": 2.14,
      "p_value": 6.5e-9,
      "frequency_european": 0.09,
      "frequency_asian": 0.04,
      "frequency_african": 0.05,
      "frequency_latin_american": 0.11,
      "description": "Major risk allele for autoimmune diabetes. Non-Asp57 allows diabetogenic peptide presentation. Key component of DR4-DQ8 risk haplotype.",
      "mechanism": "Ala57 (non-Asp) creates a positively charged P9 pocket that binds insulin B:9-23 and GAD65 epitopes with high affinity, activating autoreactive CD4+ T cells.",
      "haplotype": "DRB1*04:01-DQA1*03:01-DQB1*03:02",
      "evidence_level": "A",
      "key_references": ["PMID:21874358", "PMID:28540917"]
    },
    {
      "allele": "HLA-DQB1*02:01",
      "gene": "HLA-DQB1",
      "class": "II",
      "association": "risk",
      "phenotype": "LADA",
      "odds_ratio": 1.92,
      "ci_lower": 1.58,
      "ci_upper": 2.33,
      "p_value": 3.1e-9,
      "frequency_european": 0.12,
      "frequency_asian": 0.04,
      "frequency_african": 0.09,
      "frequency_latin_american": 0.07,
      "description": "Strong LADA risk allele. Part of DR3-DQ2 haplotype. Non-Asp57. Particularly relevant for GAD-antibody positive T2D patients.",
      "mechanism": "Presents GAD65 peptides with high efficiency. Trans-complementation with DQA1*05:01 creates the highest-risk DQ heterodimer for autoimmune diabetes.",
      "haplotype": "DRB1*03:01-DQA1*05:01-DQB1*02:01",
      "evidence_level": "A",
      "key_references": ["PMID:24595630", "PMID:28540917"]
    },
    {
      "allele": "HLA-DQB1*06:04",
      "gene": "HLA-DQB1",
      "class": "II",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.38,
      "ci_lower": 1.12,
      "ci_upper": 1.70,
      "p_value": 2.4e-3,
      "frequency_european": 0.04,
      "frequency_asian": 0.07,
      "frequency_african": 0.12,
      "frequency_latin_american": 0.06,
      "description": "Moderate risk for classical T2D (non-autoimmune). More prevalent in African populations. Associated with insulin resistance phenotype.",
      "mechanism": "May enhance inflammatory antigen presentation in adipose tissue macrophages, promoting M1 polarization and insulin resistance.",
      "haplotype": "DRB1*13:02-DQA1*01:02-DQB1*06:04",
      "evidence_level": "B",
      "key_references": ["PMID:29632382"]
    },
    {
      "allele": "HLA-DQB1*03:03",
      "gene": "HLA-DQB1",
      "class": "II",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.35,
      "ci_lower": 1.15,
      "ci_upper": 1.58,
      "p_value": 1.7e-4,
      "frequency_european": 0.05,
      "frequency_asian": 0.14,
      "frequency_african": 0.03,
      "frequency_latin_american": 0.05,
      "description": "T2D risk allele predominantly in East Asian populations. Part of DR9-DQ9 haplotype. Asp57-positive but still diabetogenic through alternative mechanisms.",
      "mechanism": "Unique P4 pocket configuration allows presentation of metabolic stress-derived peptides. Activates Th17 cells in the pancreatic microenvironment.",
      "haplotype": "DRB1*09:01-DQA1*03:02-DQB1*03:03",
      "evidence_level": "B",
      "key_references": ["PMID:26818947"]
    },
    {
      "allele": "HLA-A*24:02",
      "gene": "HLA-A",
      "class": "I",
      "association": "risk",
      "phenotype": "T2D/Beta-cell failure",
      "odds_ratio": 1.28,
      "ci_lower": 1.10,
      "ci_upper": 1.49,
      "p_value": 1.2e-3,
      "frequency_european": 0.10,
      "frequency_asian": 0.32,
      "frequency_african": 0.04,
      "frequency_latin_american": 0.15,
      "description": "Associated with accelerated beta-cell loss in T2D. Very common in East Asian and Latin American populations. Linked to fulminant T1D in Japan.",
      "mechanism": "Presents beta-cell peptides to CD8+ cytotoxic T cells with high efficiency. May accelerate beta-cell apoptosis through granzyme/perforin pathway even in T2D context.",
      "haplotype": "Independent association",
      "evidence_level": "B",
      "key_references": ["PMID:26818947"]
    },
    {
      "allele": "HLA-A*02:01",
      "gene": "HLA-A",
      "class": "I",
      "association": "risk",
      "phenotype": "T2D/Islet inflammation",
      "odds_ratio": 1.18,
      "ci_lower": 1.05,
      "ci_upper": 1.33,
      "p_value": 6.8e-3,
      "frequency_european": 0.25,
      "frequency_asian": 0.08,
      "frequency_african": 0.12,
      "frequency_latin_american": 0.15,
      "description": "Modest T2D risk in European populations. The most studied class I allele. Presents insulin-derived peptides (InsB10-18) to CD8+ T cells.",
      "mechanism": "A*02:01-restricted CD8+ T cells targeting preproinsulin signal peptide are found in T2D patients with residual autoimmunity.",
      "haplotype": "Independent association",
      "evidence_level": "C",
      "key_references": ["PMID:21874358"]
    },
    {
      "allele": "HLA-B*39:06",
      "gene": "HLA-B",
      "class": "I",
      "association": "risk",
      "phenotype": "T2D/Fulminant diabetes",
      "odds_ratio": 1.52,
      "ci_lower": 1.18,
      "ci_upper": 1.96,
      "p_value": 1.1e-3,
      "frequency_european": 0.01,
      "frequency_asian": 0.04,
      "frequency_african": 0.01,
      "frequency_latin_american": 0.03,
      "description": "Risk for rapid-onset diabetes with features overlapping T2D and fulminant T1D. Primarily reported in East Asian populations.",
      "mechanism": "Efficient presentation of viral mimicry peptides that cross-react with beta-cell antigens. May trigger acute beta-cell destruction after viral infection.",
      "haplotype": "Independent association",
      "evidence_level": "C",
      "key_references": ["PMID:26818947"]
    },
    {
      "allele": "HLA-B*54:01",
      "gene": "HLA-B",
      "class": "I",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.31,
      "ci_lower": 1.08,
      "ci_upper": 1.59,
      "p_value": 5.8e-3,
      "frequency_european": 0.005,
      "frequency_asian": 0.08,
      "frequency_african": 0.002,
      "frequency_latin_american": 0.01,
      "description": "T2D risk allele in Japanese populations. Associated with metabolic syndrome components including visceral obesity and dyslipidemia.",
      "mechanism": "Modulates NK cell activity through KIR3DL1 interaction, potentially altering adipose tissue immune surveillance.",
      "haplotype": "Independent association",
      "evidence_level": "C",
      "key_references": ["PMID:26818947"]
    },
    {
      "allele": "HLA-C*01:02",
      "gene": "HLA-C",
      "class": "I",
      "association": "risk",
      "phenotype": "T2D/Metabolic syndrome",
      "odds_ratio": 1.22,
      "ci_lower": 1.05,
      "ci_upper": 1.42,
      "p_value": 9.3e-3,
      "frequency_european": 0.07,
      "frequency_asian": 0.14,
      "frequency_african": 0.09,
      "frequency_latin_american": 0.08,
      "description": "Weak T2D association through NK cell regulation. HLA-C expression levels affect insulin resistance through adipose tissue inflammation.",
      "mechanism": "Low-expression HLA-C allele. Reduced NK cell inhibition leads to increased adipose tissue macrophage activation and insulin resistance.",
      "haplotype": "Independent association",
      "evidence_level": "C",
      "key_references": ["PMID:29632382"]
    },
    {
      "allele": "HLA-DPB1*04:01",
      "gene": "HLA-DPB1",
      "class": "II",
      "association": "protective",
      "phenotype": "T2D",
      "odds_ratio": 0.82,
      "ci_lower": 0.71,
      "ci_upper": 0.95,
      "p_value": 7.5e-3,
      "frequency_european": 0.40,
      "frequency_asian": 0.15,
      "frequency_african": 0.20,
      "frequency_latin_american": 0.25,
      "description": "Modestly protective. The most common DPB1 allele worldwide. May promote immune tolerance in the pancreatic microenvironment.",
      "mechanism": "Weak peptide-binding groove promotes low-affinity interactions, facilitating Treg induction rather than effector T cell activation.",
      "haplotype": "Independent association",
      "evidence_level": "C",
      "key_references": ["PMID:29632382"]
    }
  ],
  "snp_associations": [
    {
      "rsid": "rs9272346",
      "gene": "HLA-DQA1",
      "position": 32637622,
      "ref": "G",
      "alt": "A",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.27,
      "p_value": 1.4e-25,
      "frequency_global": 0.35,
      "description": "Strongest HLA-region SNP for T2D in GWAS. Tags DQA1*03 alleles. Genome-wide significant across multiple ancestries.",
      "evidence_level": "A",
      "reference": "PMID:30297969"
    },
    {
      "rsid": "rs2647044",
      "gene": "HLA-DQB2",
      "position": 32713854,
      "ref": "C",
      "alt": "T",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.15,
      "p_value": 3.7e-10,
      "frequency_global": 0.42,
      "description": "Independent T2D signal in the HLA class II region. May affect DQB2 regulatory elements and immune cell activation in pancreatic islets.",
      "evidence_level": "A",
      "reference": "PMID:30297969"
    },
    {
      "rsid": "rs3129889",
      "gene": "HLA-DRA",
      "position": 32563371,
      "ref": "A",
      "alt": "G",
      "association": "risk",
      "phenotype": "T2D/LADA",
      "odds_ratio": 1.32,
      "p_value": 8.2e-8,
      "frequency_global": 0.28,
      "description": "Tags DR3 and DR4 haplotypes. Proxy for high-risk DRB1 alleles in GWAS when classical HLA typing unavailable.",
      "evidence_level": "B",
      "reference": "PMID:24595630"
    },
    {
      "rsid": "rs9275596",
      "gene": "HLA-DQB1",
      "position": 32669267,
      "ref": "T",
      "alt": "C",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.19,
      "p_value": 2.5e-14,
      "frequency_global": 0.31,
      "description": "GWAS-significant T2D locus in HLA-DQB1 region. Effects may be mediated through DQB1 expression levels rather than allele-specific peptide binding.",
      "evidence_level": "A",
      "reference": "PMID:30297969"
    },
    {
      "rsid": "rs1063355",
      "gene": "HLA-DQB1",
      "position": 32660297,
      "ref": "C",
      "alt": "T",
      "association": "protective",
      "phenotype": "T2D",
      "odds_ratio": 0.88,
      "p_value": 4.1e-8,
      "frequency_global": 0.38,
      "description": "Protective variant in DQB1 coding region. Tags Asp57+ alleles (DQB1*06:02, *03:01). The Asp57 effect captured at SNP level.",
      "evidence_level": "A",
      "reference": "PMID:30297969"
    },
    {
      "rsid": "rs2395185",
      "gene": "HLA-DRA",
      "position": 32562437,
      "ref": "T",
      "alt": "G",
      "association": "risk",
      "phenotype": "T2D",
      "odds_ratio": 1.12,
      "p_value": 7.8e-9,
      "frequency_global": 0.33,
      "description": "HLA-DRA region variant associated with T2D. May affect DRA expression and antigen presentation efficiency.",
      "evidence_level": "B",
      "reference": "PMID:30297969"
    }
  ],
  "haplotype_risks": [
    {
      "haplotype": "DR3/DR4 (DRB1*03:01/DRB1*04:01)",
      "risk_category": "very_high",
      "odds_ratio": 3.50,
      "phenotype": "LADA",
      "description": "Highest-risk HLA genotype for LADA. Compound heterozygotes generate trans-complementary DQ heterodimers (DQA1*05:01/DQB1*03:02) with extreme diabetogenic capacity.",
      "frequency": 0.024,
      "color": "#e74c3c"
    },
    {
      "haplotype": "DR4-DQ8 (DRB1*04:01-DQB1*03:02)",
      "risk_category": "high",
      "odds_ratio": 2.40,
      "phenotype": "T2D/LADA",
      "description": "High-risk haplotype. DQ8 (DQA1*03:01-DQB1*03:02) presents insulin B:9-23 with high affinity. Risk amplified by DRB1*04:01 linkage.",
      "frequency": 0.065,
      "color": "#e67e22"
    },
    {
      "haplotype": "DR3-DQ2 (DRB1*03:01-DQB1*02:01)",
      "risk_category": "high",
      "odds_ratio": 2.20,
      "phenotype": "LADA/T2D",
      "description": "High-risk haplotype for LADA. DQ2 (DQA1*05:01-DQB1*02:01) is the primary celiac disease allele and also presents GAD65 efficiently.",
      "frequency": 0.095,
      "color": "#f39c12"
    },
    {
      "haplotype": "DR9-DQ9 (DRB1*09:01-DQB1*03:03)",
      "risk_category": "moderate",
      "odds_ratio": 1.55,
      "phenotype": "T2D",
      "description": "Moderate risk, primarily in East Asian populations. DR9 is the major T2D-HLA risk allele in Japan.",
      "frequency": 0.035,
      "color": "#f1c40f"
    },
    {
      "haplotype": "DR15-DQ6 (DRB1*15:01-DQB1*06:02)",
      "risk_category": "very_protective",
      "odds_ratio": 0.35,
      "phenotype": "T2D/LADA/T1D",
      "description": "Strongest protective haplotype. DQB1*06:02 (Asp57) blocks diabetogenic peptide presentation. Even single copy confers dominant protection.",
      "frequency": 0.125,
      "color": "#2ecc71"
    },
    {
      "haplotype": "DR7-DQ2 (DRB1*07:01-DQB1*02:02)",
      "risk_category": "protective",
      "odds_ratio": 0.65,
      "phenotype": "LADA",
      "description": "Protective against LADA. Note: DQB1*02:02 (not *02:01) â€” the single amino acid difference at position 135 changes disease risk dramatically.",
      "frequency": 0.085,
      "color": "#27ae60"
    },
    {
      "haplotype": "DR13-DQ6 (DRB1*13:01-DQB1*06:03)",
      "risk_category": "protective",
      "odds_ratio": 0.70,
      "phenotype": "T2D",
      "description": "Protective haplotype with anti-inflammatory properties. Associated with lower CRP and IL-6 levels in metabolic syndrome.",
      "frequency": 0.055,
      "color": "#1abc9c"
    }
  ],
  "biological_mechanisms": [
    {
      "id": "antigen_presentation",
      "name": "Antigen Presentation to CD4+ T Cells",
      "description": "HLA Class II molecules present peptides from extracellular proteins (including islet autoantigens) to CD4+ helper T cells. The specificity of the peptide-binding groove determines which antigens trigger immune responses.",
      "relevance_to_t2d": "In LADA and autoimmune T2D, specific HLA-DR/DQ alleles present beta-cell autoantigens (GAD65, IA-2, insulin) leading to T cell-mediated islet destruction.",
      "icon": "antigen"
    },
    {
      "id": "asp57_effect",
      "name": "DQB1 Position 57 (Asp57) Effect",
      "description": "The single most important amino acid position for diabetes risk. Aspartic acid at position 57 of DQB1 forms a salt bridge that determines the P9 binding pocket structure.",
      "relevance_to_t2d": "Non-Asp57 alleles (Ala, Val, Ser) create a positively charged pocket that binds insulin and GAD65 peptides with high affinity, activating diabetogenic T cells.",
      "icon": "molecular"
    },
    {
      "id": "trans_complementation",
      "name": "Trans-Complementary DQ Heterodimers",
      "description": "In heterozygous individuals, DQA1 and DQB1 chains from different haplotypes can pair to form novel trans-encoded DQ molecules not present in either parent.",
      "relevance_to_t2d": "DR3/DR4 heterozygotes form DQA1*05:01/DQB1*03:02 trans-dimer, the single most diabetogenic HLA molecule. Explains the extreme risk of the DR3/DR4 genotype.",
      "icon": "network"
    },
    {
      "id": "adipose_inflammation",
      "name": "Adipose Tissue Immune Regulation",
      "description": "HLA molecules on adipose tissue macrophages and dendritic cells regulate local immune responses. Class II expression increases in obesity.",
      "relevance_to_t2d": "Specific HLA alleles promote M1 macrophage polarization and Th1/Th17 responses in visceral adipose tissue, exacerbating insulin resistance independent of autoimmunity.",
      "icon": "inflammation"
    },
    {
      "id": "nk_cell_regulation",
      "name": "NK Cell Regulation via HLA Class I/KIR",
      "description": "HLA class I molecules serve as ligands for KIR (Killer Immunoglobulin-like Receptors) on NK cells. KIR/HLA interactions regulate NK cell activation threshold.",
      "relevance_to_t2d": "KIR/HLA-C genotype combinations affect adipose tissue NK cell activity, influencing macrophage recruitment and insulin resistance in obesity-related T2D.",
      "icon": "nk_cell"
    },
    {
      "id": "gut_immune_axis",
      "name": "Gut-Immune-Metabolic Axis",
      "description": "HLA molecules present bacterial-derived peptides from gut microbiota. Intestinal permeability increases in T2D, exposing immune cells to more bacterial antigens.",
      "relevance_to_t2d": "Specific HLA alleles modulate the immune response to gut bacterial antigens, affecting systemic inflammation, incretin signaling, and metabolic endotoxemia.",
      "icon": "gut"
    }
  ]
}
